These specific effects of SOCS2 in the context of IL-1β are important because IL-1β-signaling is known to be associated with tumor progression in certain myeloid disorders such as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) [15]. Here, IL1B is linked to neoplasm.